Aubry Sylvain, Pellet-Rostaing Stéphane, Fournier Dit Chabert Jérémie, Ducki Sylvie, Lemaire Marc
ICBMS, Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Laboratoire de Catalyse et Synthèse Organique, 43 boulevard du 11 novembre 1918, Villeurbanne, F-69622, France.
Bioorg Med Chem Lett. 2007 May 1;17(9):2598-602. doi: 10.1016/j.bmcl.2007.01.108. Epub 2007 Feb 7.
Some (1,3')-bis-tetrahydroisoquinolines were reported as scaffold intermediates for the synthesis of pentacyclic piperazine core alkaloids and their cytotoxicity against cancerous cell lines was evaluated. The NMR and X-ray structural assignments revealed an anti C3-C11 backbone stereochemistry of piperazine structures. Inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinoline scaffolds and pentacyclic piperazine systems was assessed against three human cancer cell lines (K562 myelogenous leukemia, A549 lung carcinoma, MCF-7 breast adenocarcinoma) and both mouse tumor cell lines of blood (P388) and lymphocytic (L1210) leukemia with considerable activity against the latter. The cell cycle analysis was also studied by flow cytometry measurement on K562 cell line.
一些(1,3')-双四氢异喹啉被报道为合成五环哌嗪核心生物碱的骨架中间体,并评估了它们对癌细胞系的细胞毒性。核磁共振(NMR)和X射线结构分析揭示了哌嗪结构的反式C3-C11主链立体化学。针对三种人类癌细胞系(K562髓性白血病、A549肺癌、MCF-7乳腺腺癌)以及血液(P388)和淋巴细胞(L1210)白血病的两种小鼠肿瘤细胞系,评估了(1,3')-双四氢异喹啉骨架和五环哌嗪系统对癌细胞增殖的抑制作用,对后者具有相当的活性。还通过对K562细胞系进行流式细胞术测量来研究细胞周期分析。